4//SEC Filing
Langren Carl W. 4
Accession 0001126234-20-000046
CIK 0001126234other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:22 PM ET
Size
8.4 KB
Accession
0001126234-20-000046
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Langren Carl W.
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-01+45,000→ 45,000 totalExercise: $7.87Exp: 2030-03-31→ Common Stock (45,000 underlying) - Award
Common Stock
2020-04-01+9,000→ 11,238 total
Holdings
- 5,521(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2009 Equity Incentive Plan, as amended, (the "Plan") that were received as an award, for no consideration. The RSUs vest in a series of four successive annual installments beginning on April 1, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F2]Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on May 1, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001591245
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:22 PM ET
- Size
- 8.4 KB